#1 Berlin-Brandenburg Reception | MEDICA 2023

… invites you to join us for the Berlin-Brandenburg Reception. BERLIN-BRANDENBURG RECEPTION | MEDICA 2023 | DÜSSELDORF  13 NOVEMBER 2023, 6 p.m. | HALL 15, BOOTH K22  Germany’s Capital Region…

#2 HealthCapital Berlin Brandenburg Reception | Medica 2019

…The HealthCapital region cordially invites you to join us for the HealthCapital Berlin Brandenburg Reception MEDICA | Düsseldorf | 18 November 2019 | 6 p.m. | Hall 15, Booth L35 Welcome Note Dr. Kai Bindseil, Cluster…

#3 Berlin-Brandenburg Reception | Medica 2022

… to join us for the Berlin-Brandenburg Reception (Hall 15, Booth K22). BERLIN-BRANDENBURG RECEPTION | MEDICA 2022 | DÜSSELDORF 14 NOVEMBER 2022, 6 P.M. | HALL 15, BOOTH K22 "Now more than ever - Mastering the…

#4 Meet us at MEDICA 2023

…Joint Berlin-Brandenburg "Medical Technology" Booth

#5 Meet us at MEDICA 2022

…Joint Berlin-Brandenburg "Medical Technology" Stand

#6 Guided Tour for international guests at MEDICA 2019

…The Capital Region Berlin-Brandenburg will be present again at MEDICA fair this year with a joint booth of more than 20 exhibitors that are looking for new business opportunities. Therefore, we invite all our…

#7 MEDICA 2019

…Let’s connect at the world’s biggest medical fair

#8 MEDICA Healthcare Brokerage Event 2021

… On the occasion of MEDICA 2021 (15 - 18 November), the global No. 1 meeting place for the medical sector, ZENIT GmbH together with the Healthcare Sector Group of the Enterprise Europe Network (EEN) will…

#9 MEDICA 2018

… With more than 300 companies and some 13,500 employees, Berlin-Brandenburg is one of the leading medical technology locations in Europe. Many of the region's innovative companies are active in a wide array…

#10 Medtech & Digital Health

…Contact Medtech A center for medical technology with over 350 companies, among them world leaders. Digital health As a leading location for health and IT, we are pioneers in the development of digital health…

#11 HealthCapital Berlin Brandenburg Reception

…We cordially invite you to join us for the HealthCapital Berlin Brandenburg Reception at MEDICA in Düsseldorf.

#12 COVID-19: Despite the prospect of vaccines, tests are the tool of choice

… whose cure requires individual treatment methods.You are welcome to visit our joint booth at medica.diagnostiknet-bb.de DiagnostikNet-BB…

#13 Diagnostics and Research Tools Digital Partnering Conference

… medicine and life science research tools. Meet your partner at DxPx. Always parallel to virtual.MEDICA! - Virtual One-to-one meetings made possible by our partnering platform - Access to virtual…

#14 Fraunhofer Institutes for Applied Polymer Research IAP developed 3D printing that enables tissue with customized shape

… IAP and for Laser Technology ILT as well as the BG Klinik Ludwigshafen will be presented at the MEDICA medical technology trade fair in Düsseldorf from November 15 to 18 in Hall 3, Booth E74.

#15 Revolutionizing the production of novel diagnostics with cost-effective Roll-to-Roll imprinting

… More information: www.r2r-biofluidics.eu. Visit our brand-new website: www.scienion.com Visit us MEDICA 2018 in Düsseldorf, Germany November 12-15, 2018 Booth 3A42 in hall 3 About SCIENION SCIENION…

#16 9TH ANNUAL HEALTHTECH INVESTMENT FORUM

… Keynote Speakers in 2021 Included: ​Eyal Zimlichman, Deputy Director General, CMO & CIO, Sheba Medical Center Robin Shattock, Professor of Mucosal Infection & Immunity, Imperial College London ​Sir…

#17 MIT – Latin America vs. COVID-19

… Participants of all academic and professional backgrounds are welcome! Technical or medical experience is always helpful, but it is not required.  DO I HAVE TO BE AN MIT STUDENT OR MIT…

#18 BIO-Europe

… up-and-coming companies and cultivate existing partnerships. These pave the way for innovations and medical breakthroughs. Be a part of it too! With an exclusive 10% discount on the valid ticket price. The…

#19 22ND ANNUAL BIOTECH IN EUROPE FORUM

… Global Head, Neuroscience Search & Evaluation, AbbVie, Inc. Mythili Koneru, Chief Medical Officer, Marker Therapeutics, Inc. Natalie Mount, CEO, Adaptate Biotherapeutics Ltd. Nathalie ter…

#20 Sectors

…Biotech & Pharma Medical Technologies Healthcare Health Tourism Life Sciences Report 2022|2023 Digital Health

#21 Health-related Tourism

Medical Tourism in and around Berlin Health and Wellness Tourism in Berlin-Brandenburg

#22 digital HealthCapital @ conhIT 2018

… countless possible applications for the health sector, for example in the operating theatre, telemedical applications, for training and e-learning, or for the optimization of logistics processes. In…

#23 European Medical Tourism & Global Healthcare Congress

… stories, and challenges different countries face in light of the increase in patient mobility. Medical Tourism and Health Tourism are key components to the European economy and the future of these…

#24 DMEA - Connecting Digital Health

… up here. ------------------- Workshop “ Healthcare Thinking - The human in the center of medical innovation“ 09.04.2019 | 12:00 to 1:00 p.m. Room Zuse 6, Hall 4.1/7 Organiser: Cluster ICT,…

#25 The MedTech Forum & The Global MedTech Compliance Conference

…The MedTech Forum is the largest health and medical technology industry conferences in Europe and a key event since 2007. Join industry leaders, leading innovators and investors to discuss the future opportunities in…

#26 Faster from the laboratory to the patient: Initiative of Fraunhofer, Helmholtz and Hochschulmedizin promotes pilot project in the health sector

… In the development of new medications and medical engineering, there is a gap between the discovery of new potential active ingredients and products and their further development into medicinal products and medical…

#27 NOXXON PHARMA N.V. REPORTS 2017 FINANCIAL RESULTS

… feedback at conferences such as the American Society Neuro-Oncology, the European Society of Medical Oncology and the American Association of Cancer Research. These interactions have shaped our plans…

#28 Heart Attack and Stroke Risk Also Elevated in Women with Obesity Who Are Metabolically Healthy

… of Tübingen, and the Paul Langerhans Institute Dresden of Helmholtz Zentrum München at the University Medical Center Carl Gustav Carus of TU Dresden, associated partners at the universities in Heidelberg,…

#29 MOLOGEN reached key strategic milestones and successfully implements capital measures in 2017

… successful further product development is above all owing to the efforts of the new Chief Medical Officer, Dr Matthias Baumann, who joined the Executive Board of MOLOGEN in May 2017.  Signing…

#30 TU Berlin start-up Cellbricks wins World Summit Award

… "Organ as a Service" was developed, which combines 3D-Biodruck as a disruptive technology in the medical sector with a web-based ecosystem. The goal is to promote the use of 3D-Biodruck in medical research…

#31 Startups and Pharma in times of DVG – virtual event by Pfizer & APX

… space and is here to stay! As of summer 2020, Germany pioneers the prescription and reimbursement of medical apps by statutory healthcare insurances, making Germany the first country worldwide to partially…

#32 sphingotec is adding an advanced POC testing platform to portfolio

… sphingotec GmbH develops innovative biomarkers for diagnosis, prediction and monitoring of acute medical conditions, such as acute heart failure, acute kidney injury and circulatory shock, in order to…

#33 MOLOGEN and ONCOLOGIE: Global assignment and codevelopment agreement relating to MOLOGEN’s lead compound lefitolimod

… agreement, MOLOGEN would carry out certain manufacturing activities to supply the clinical medication. ONCOLOGIE would also obtain a Right of First Refusal to license the optioned products, EnanDIM®…

#34 TissUse establishes a liver-endocrine tissues multi-organ model for risk assessment with Bayer

… long periods of time. This technology is envisioned to clarify how the human organism reacts to new medication, cosmetic substances or chemicals without expensive animal testing. “Miniaturized human…

#35 Portrait: 10 Years of The World Health Summit in Berlin

… an international network of excellent universities, research institutes, and more than 130 worldwide medical and scientific academies. The “M8 Alliance” was founded in 2009 on the occasion of the first World…

#36 Digital attack on cancer

… modification or a specific form of prostate cancer. Or help to prevent severe side effects of the medications used by selected patients. Communication standards in healthcare “We need communication…

#37 Call for applicants - Solicit Proposals for Drug Discovery Research

… orally. ・ High priority will be given to research projects that focus on the field of orthopedics, the medical field where Asahi Kasei Pharma directs its research and development efforts. (Proposals involving…

#38 Europe looks to cells for a healthier future

… interdisciplinary and international cooperation has the potential to raise health research, and thus medical care to a new level. Therefore, we are very pleased that the EU is financing the LifeTime consortium.…

#39 Clovis Oncology Acquires Rights to FAP-Targeted Radiopharmaceutical Program from 3B Pharmaceuticals

… targeted radiopharmaceutical drugs and diagnostics for oncology indications with a high unmet medical need. The initial focus is on developing a peptide-targeted radionuclide therapy (PTRT) and imaging…

#40 Advancing knowledge for the clinical and public health response to the 2019-nCoV epidemic

… covering investigation of therapeutic and/or vaccines should consider engaging with the European Medical Agency (EMA) to ensure adequacy of the proposals from a regulatory point of view, i.e. via the…

#41 Digital collaboration on rare diseases

… of almost six million euros over two years. The project leverages the infrastructure of the BMBF’s Medical Informatics Initiative (MII). Its aim is to facilitate the privacy-compliant sharing of information…

#42 Europe’s Largest Initiative Launches to Accelerate Therapy Development for COVID-19 and Future Coronavirus Threats

… Switzerland, the UK and the US, and is led by VRI-Inserm (French National Institute of Health and Medical Research, Paris, France), Janssen Pharmaceutica NV, one of the Janssen Pharmaceutical Companies of…

#43 Aignostics raises €5m Seed Round to advance AI-powered pathology

… our closeness to Charité and TU Berlin, we develop our applications side-by-side with computer scientists, medical researchers and surgical pathologists as “end users” alike”, Viktor Matyas, CEO of Aignostics,…

#44 Berlin Heart: Relief for children with serious coronary diseases

… a heart transplant, to play, move and learn.  Complex medical technology products require specialist knowledge in the development…

#45 "Germany has done nothing better than other countries, it just acted earlier.”

… in the past. Christian Drosten: Things have to change in science, too: In Germany, for example, medical research is very cancer-oriented. Infectious diseases are extremely important in medicine, and we are…

#46 EU AWARD CELEBRATES IMPACT OF EXCOR® ACTIVE ON CHILDREN WAITING FOR HEART TRANSPLANTATION

… clinics, 28 institutes and six interdisciplinary units, the University Hospital covers the entire medical spectrum. Excellently qualified teams of doctors, nurses and scientists are competently committed to…

#47 GeneQuine Biotherapeutics Secures More Than €9 Million in Series A Financing and Non-Dilutive Funding to Advance Gene Therapy Pipeline for Musculoskeletal Diseases

… gene therapies for treatment of intervertebral disc degeneration. Despite the tremendous unmet medical need in the treatment of intervertebral disc degeneration as one of the main causes for chronic low…

#48 New cancer-fighting immunotherapy enters clinical trials

… and gene therapy is safe for patients,” says Professor Antonio Pezzutto, who is leading the study at the Medical Department, Division of Hematology, Oncology and Tumor Immunology on Charité’s Campus Benjamin…

#49 Dopavision Closes €12 Million Series A Round to Advance Digital Childhood Myopia Therapeutic Through Clinical Trials

… by providing transformative treatments and addressing the disease at an early stage, providing medical benefits for later years of life. The proceeds will be used to fund the clinical development of…

#50 Cystic Fibrosis – Increasing numbers of patients benefit from improved treatment

… is one of the largest employers in Berlin. At Charité, the areas of research, teaching and medical care are closely interlinked. 4,707 of its employees work in the field of nursing, with a further…

#51 Lindis Blood Care successfully closes follow-on financing round

… a company aiming to set a new Gold Standard for blood management during cancer surgeries with its medical device CATUVAB®, today announced the closing of a follow-on financing round. The new investment will…

#52 Two ERC Consolidator Grants go to MDC researchers

… by the European Research Council (ERC). The two junior group leaders at the Berlin Institute for Medical Systems Biology (BIMSB) of the Max Delbrück Center for Molecular Medicine in the Helmholtz…

#53 Computational Biology – Shaping medical progress with computer-aided data analysis

… and has become indispensable in research and practice. With its mix of companies, research and medical institutions, the Berlin-Brandenburg metropolitan region offers an optimum environment for the…

#54 Bayer’s BlueRock Therapeutics establishes European site for cell therapy innovation

… share a commitment to developing new therapies to treat devastating diseases in areas of high unmet medical need. Since the inception of BlueRock in 2016 by Versant Ventures and Bayer AG, the company has grown…

#55 Ludovic Vallier grows liver tissue from stem cells

… of Regenerative Medicine affiliated to the Department of Surgery and Director of the Cambridge Biomedical Research Centre hIPSCs (human induced pluripotent stem cells) core facility. He also became Co-Deputy…

#56 Horizon Europe: Charité coordinates four new EU projects

… research consortia: 4DPicture: The aim of the project, which is led by the Erasmus University Medical Center (Erasmus MC) in Rotterdam, is to make data-based decision-support tools an integral part of…

#57 MDC researchers are part of international consortium that discovers how pathogenic gene variants lead to heart failure

… who spearheaded the project are Christine Seidman, professor of medicine and genetics at Harvard Medical School and a cardiologist at Brigham and Women’s Hospital; Jonathan Seidman, professor of genetics at…

#58 Charité study provides evidence to support suspicion that COVID-19 might trigger chronic fatigue syndrome

…e first wave of the pandemic,” says Prof. Dr. Carmen Scheibenbogen, Acting Director of Charité’s Institute of Medical Immunology on Campus Virchow-Klinikum. Prof. Scheibenbogen also oversees the work of the ‘Charité…

#59 Aignostics Raises €14m Series A to Advance AI-powered Pathology

… promising early- and growth stage life science companies in the fields of biotechnology, therapeutics, medical technology, diagnostics and digital health. With funds totalling more than €1.2 billion, thereof €590…

#60 Charité researchers win six ERC Starting Grants

… diseases. Dr. Dr. René Hägerling is a physician and scientist at the Institute of Medical Genetics and Human Genetics at Charité. He heads the Lymphovascular Medicine and Translational 3D…

#61 Special Topic | Women in the healthcare sector

… professional associations and through the commitment of individuals who deal with the topic. The Medical Association in Berlin also organizes events. According to Mandy Mangler, there are also several Head…

#62 Innovative research and clinical care under one roof: Rahel Hirsch Center for Translational Medicine of the BIH and Charité opens its doors

… used by the Berlin Institute of Health at Charité (BIH) and Charité – Universitätsmedizin Berlin for biomedical research, outpatient care and clinical studies. The BIH and Charité have been united for just over…

#63 Max Delbrück Center discovers mechanism that prevents the human immune response from overshooting

… planning the next phase of the study with his group leader Blankenstein and scientists at University Medical Center Freiburg. Together, they are going to test their latest findings on a new model. “We want to…

#64 International research team with Charité and Max Planck Institute for Molecular Genetics discover that protein droplets may cause many types of genetic disease

… because we did not know how to look for it,” says Denise Horn, a clinical geneticist at the Institute of Medical and Human Genetics at Charité – Universitätsmedizin Berlin. In collaboration with scientists at the…

#65 Special Topic | Long COVID in Berlin-Brandenburg – research, networks and engagement for better care

… and psychotherapy. A comprehensive approach is taken by the “Post COVID Network” of Charité University Medical Center Berlin. Various specialized outpatient clinics of Charité have joined forces in the network,…

#66 BIO Asia–Taiwan 2020 Online + Live

… success and exceeded all expectations, with more than 1,500 from 25 countries representing biomedical, pharmaceutical, genomics, biotech services, equipment and instruments, academic research,…

#67 LIQUID CHROMATOGRAPHY IN SARS-COV-2 RESEARCH

… number of KNAUER chromatography products and how they can help to discover, understand and develop medical treatment against SARS-CoV-2 infection. Who In this webinar Anja Roden, Dr. Maria Glanz and Dr.…

#68 AskBio Receives European Commission Orphan Drug Designation through its EU-Based subsidiary BrainVectis for AB-1003, a Novel Investigational AAV Gene Therapy for the Treatment of Limb-Girdle Muscular Dystrophy (LGMD)

… LGMD2I/R9.  “The EC orphan drug designation for AB-1003 is an important recognition of the unmet medical need in LGMD, which has no approved therapy,” said Sheila Mikhail, Co-Founder & CEO, AskBio. “The…

#69 “Turning research into health!” – The Berlin Institute of Health at Charité (BIH) turns 10 years old

… (BIH) was officially founded exactly 10 years ago today, March 25, 2013. The aim was to advance medical translation and thus accelerate the transfer of basic research findings from the bench to the…

#70 Supporting innovation in biomedicine

… have a certain inherent value in the marketplace. “These are research findings that could help meet a medical need by offering, for example, the prospect of new therapeutic options for diseases that are…

#71 Nasal vaccine, developed by researchers from Berlin, to prevent COVID-19 passes first tests

… Regulation Lab, which is led by Professor Markus Landthaler at the Berlin Institute for Medical Systems Biology of the Max Delbrück Center (MDC-BIMSB). In an ideal scenario, a live intranasal…

#72 Interview | Prof. Dr. Petra Ritter, Head of TEF-Health and Dr. Dirk Schlesinger, Head of TÜV AI Lab

… start-ups and researchers alike, with no signs of slowing down. Healthcare is no exception, but new medical devices and procedures must be proven safe and useful before they can be used on patients. And while…

#73 CENTOGENE and Lifera, a Biopharma Company Owned by the PIF, Enter Strategic Collaboration – Forming Saudi Arabian Joint Venture to Increase Access to Leading Data-Driven Multiomic Testing and Securing CENTOGENE $30 Million Investment

… driven by a comprehensive diagnostic portfolio that goes beyond standard laboratory testing and medical interpretation. This collaboration will also enable biopharma research in rare diseases and provide…

#74 Brandenburg University of Technology Cottbus-Senftenberg have discovered a novel treatment approach for soft tissue tumors

… technology transfer program SPARK-FLI helps to translate fundamental scientific findings from biomedical research into diagnostics or medical applications and ensures that government-funded research…

#75 Special Topic | Well-trained professionals in the healthcare industry – The metropolitan region has a lot to offer

… region that are releasing graduates into the professional world. For example, Germany’s largest school for medical technology – the Oberstufenzentrum Informations- und Medizintechnik (OSZ IMT) – is based in Berlin…

#76 ERC Starting Grants for two Charité researchers

… as well as the shift in how iatrogenic risk is handled since the disastrous impact of the medication thalidomide in the 1950s to 1960s. Biomathematician Dr. Maik Pietzner is studying potential new…

#77 Scientists of the MDC-BIMSB have developed a technology to initiate and control organoids’ functioning and interacting

… process. But now researchers led by Professor Nikolaus Rajewsky, Director of the Berlin Institute for Medical Systems Biology of the Max Delbrück Center (MDC-BIMSB), have published a paper in Nature Methods…

#78 500 Startups Kobe Accelerator for COVID-19 Emerging Technology

… of the pandemic, including preventive health tools, accurate tracking of infections, remote medical care, remote work and study, and efficient food distribution, among others. The fifth 500 KOBE…

#79 RegMed Forum 2020: Viruses and heart diseases

… treatment approaches, such as cell therapies and supportive medical devices.  The last part of the event will be dedicated to an open panel discussion, both…

#80 Establishment of the National Center for Tumor Diseases (NCT) Berlin

… The diseased cells serve as a proxy or surrogate for the patient’s disease – the potential effect of medication can be tested without subjecting the patient to harmful side effects. Artificial intelligence…

#81 Special topic | Cardiovascular health in Berlin-Brandenburg

… from Friede Springer gGmbH and seven million euros from the state of Berlin.  The German Medical Technology Association (BVMed) also highlighted the importance of prevention and the need to improve…

#82 Releasing “brakes” in the brain - Researchers use deep brain stimulation to localize disrupted neural pathways

… private supporters Larry and Kana Miao, the Agence nationale de la recherche, the NIHR UCLH Biomedical Research Centre, Scuola Superiore Sant'Anna, the German Research Foundation (DFG), the German…

#83 BIOMEDICA ON THE MOVE

…Die BIOMEDICA ON THE MOVE ist für den 8. Oktober 2020 an dem Universitätsklinikum CHU in Liège, Belgien geplant. Diesmal lautet das Thema: “Business Opportunities in Wearables & Artificial Intelligence for Health”.

#84 Virtual Partnering Event – Meet with Johnson & Johnson Innovation in Germany

… solutions through value-creating partnerships. Our expertise spans multiple sectors: consumer, medical devices, pharmaceuticals, digital health and global public health. Given the travel and safety…

#85 Coffee Break Life Sciences Start-ups | Clinical trials in the medical devices area: tips and tricks for CTA negotiation

Everything that interests start-ups in the life science sector - our expert talk: entertaining and informative. Every third Wednesday of the month in 2024. Register now, don't miss a single

#86 Coffee Break Life Sciences Start-ups | Regulatory peculiarities: AI used in medical devices, combination products and companion diagnostics

Everything that interests start-ups in the life science sector - our expert talk: entertaining and informative. Every third Wednesday of the month in 2024. Register now, don't miss a single

#87 BIH Digital Health Forum

… is the tech behind precision medicine? Moderator: David Higgins, Machine Learning Specialist in the medical field; co-founder of several start-ups Speakers: Dr. Altuna Akalin, Head of Bioinformatics at the…

#88 MIT Covid19 Challenge

… Further, the situation has made it difficult for those affected by the pandemic to seek prompt medical attention or ancillary support services to effectively combat COVID19 and other critical illnesses.…

#89 German-Polish Dialogue on the Healthcare Sector

… Both countries – Poland as well as Germany- have areas characterised by decentralised and insufficiant medical infrastructures. The COVID-19 pandemic made the problems of both health care systems obvious, but…

#90 AbbVie Partnering Day

… is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people’s lives across several key…

#91 Pioneering research: non-invasive brain stimulation with superior accuracy - ERC Consolidator Grant for Charité neuroscientist Surjo Soekadar

… simulating the perception of touch when a person controls a prosthesis, for example. BCI systems are medically useful in areas such as neurological rehabilitation, where they can be used for goals like…

#92 Boost for Berlin’s biotech sector

… The inauguration is a good day for the many people in Berlin and around the world who stand to benefit medically from the work being done in Buch,” stated Kai Wegner, Berlin’s Governing Mayor.   Senator…

#93 Bayer invests 250 million USD in new cell therapy manufacturing facility in the U.S.

… of motor function and symptoms such as tremors, muscle rigidity, and slowness of movement. Even with medication, the symptoms of Parkinson’s disease can fluctuate during the course of the day. According to the…

#94 Bayer’s darolutamide plus androgen deprivation therapy (ADT) significantly extends metastasis-free survival with a favorable safety profile compared to placebo plus ADT in non-metastatic castration-resistant prostate cancer

… can impact their overall well-being, prognosis and compliance with the treatment as well as other medications that are typical for this patient population. These data are exciting for the prostate cancer…

#95 Digital Medicine Week 2021

… life for patients. Be there when the hih opens the digital gates, giving the stage to patients, medical entrepreneurs, DiGA (app) manufacturers, researchers, experts in evidence generation, medical…

#96 Matchmaking @ Health Valley Event 2021

… Eureka/Eurostars and Active and Assistive living (AAL) programmes in the area of digital health, medical devices and personalized medicine. We welcome participants from start-ups, scale-ups, corporates,…

#97 Pharmacokinetics - Essentials for project managers in biotech companies

… pharmacokinetic questions. natural scientists, PhD students and Postdocs of natural scientific and medical degree programs who are interested in getting an overview on pharmacokinetics in clinical…

#98 16th Current Topics in Bioinformatics: (Deep) Learning from -OMICS Data?

…With the increase of OMICS techniques a huge amount of molecular data are generated in modern biomedical research. In combination with medical images and clinical data, the field of omics revolutionized the…

#99 Protecting your innovation – Workshop on intellectual property and regulatory exclusivity in biotech & pharma

… patents in Europe and the world Patentable subject-matter in the field of medicine: Overview and second medical use (new medical purpose) Digression: Patenting of medical devices with “double function”…
Show more items